Navigation Links
27-Year Pharmaceutical Marketing Leader Ruth Desmond Joins Stream57

NEW YORK, Jan. 13 /PRNewswire/ -- Stream57, the leading provider of fully customizable webcasting and streaming media communications, is proud to announce that pharmaceutical industry veteran Ruth Desmond has joined the company as Vice President, Healthcare, bringing nearly three decades of experience, knowledge and success to the virtual communications software company. Dr. Desmond assumed the role at the beginning of the new year.

"Stream57 is at the front of the pack and the gap is widening," Desmond said. "I started working with Stream57 several years ago from the other side of the table. I challenged them with new initiatives and aggressive timelines, and found them to be the most customer-centric and flexible vendor that I have worked with in my 27 years in the industry. They always delight clients and customers with their work, and I'm extremely grateful to be a part of such a talented team."

Dr. Desmond began her career in R&D for Eli Lilly and Company and Merck & Co., Inc., but soon took positions in strategic product planning and marketing, most recently serving as Executive Director, Global e-Marketing for Merck. Having worked with Stream57's StreamLine webcasting and media delivery platform for a variety of products and divisions, Dr. Desmond is very familiar with the advantages of using emerging technology in the pharmaceutical and medical marketing business.

"The fact that Stream57 offers project management as well as an amazing development team is key to making projects move efficiently and execute flawlessly," she continued. "If there is a need for physicians or patients, Stream57 can make it happen."

"We are thrilled to add Ruth to our team," Stream57 President Ben Chodor said. "I have the utmost respect for Dr. Desmond - her consistent industry-leading success, impeccable character and unmatched ability to foresee trends and opportunities - we couldn't design a more ideal candidate to lead our healthcare initiatives. Ruth's endorsement by way of embracing and promoting our technology was the most flattering and humbling praise to receive; we couldn't be more excited about where her influence and reputation will take us now."

Dr. Desmond joins Stream57 as the company comes off a banner year. In 2008, Stream57 nearly doubled in size, executed first-time projects for several new industries such as publishing and consumer product marketing, and received multiple awards and accolades including a prize at the Medical Marketing & Media Awards.

"One of my favorite quotes is from the great philosopher, Wayne Gretzky. I think he also played a little hockey," Desmond joked. "He said, 'I skate to where the puck is going to be, not where it is.' Right now, the puck is blazing toward multi-channel marketing and nobody does it better than Stream57."

For interviews or additional information, please contact Andrew Parker at 212-909-2550 x1020 or

About Stream57

Stream57 is an energetic team that believes in the power of the Internet for learning, marketing and entertainment, with offices in New York and London. StreamLine 2.9.5, Stream57's cutting-edge webcast and rich media software suite, brings a new level of interactivity to online video presentations and e-learning. Recently named #745 in the Inc. 5000 List of Fastest Growing Private Companies, Stream57 was founded in 2001 by President Ben Chodor, and has provided software and services for rich media delivery, webcasting and e-learning solutions for a wide range of distinguished clients, including several Fortune 1000 corporations, charities, B2B publishers, higher education institutions and healthcare organizations. For more information on Stream57, please call 212-909-2550 or visit

SOURCE Stream57
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
3. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
4. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
6. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
8. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
9. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
10. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Pharmaceutical Manufacturing Quality: Optimizing Your Internal Process for FDA Compliance
Post Your Comments:
(Date:11/27/2015)... ... , ... CBD College is proud to announce that on November ... to its Diagnostic Medical Sonography program. CBD College is honored to join this very ... and universities in the state of California make the cut. CBD College is officially ...
(Date:11/27/2015)... ... November 27, 2015 , ... Indosoft Inc., developer and ... of Asterisk 11 LTS (Long Term Support) into its Q-Suite 5.10 product line. ... 5.10 up-to-date with a version of Asterisk that will receive not only security ...
(Date:11/26/2015)... ... November 26, 2015 , ... Somu Sivaramakrishnan announced today that ... Somu now offers travelers, value and care based Travel Services, including exclusive pricing ... well as, cabin upgrades and special amenities such as, shore excursions, discounted fares, ...
(Date:11/26/2015)... , ... November 26, 2015 , ... ... medical opinion process, participated in the 61st annual Employee Benefits Conference. The Employee ... took place Sunday, November 8th through Wednesday, November 11th, 2015. The conference was ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... ... potentially more aggressive than those found on mammography, according to a study published ... of additional cancers not seen on mammography may necessitate a change in treatment. ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 ... the "Radioimmunoassay Market by Type (Reagents ... Industry, Academics, Clinical Diagnostic Labs), Application (Research, ... to 2020" report to their offering. ... the addition of the "Radioimmunoassay Market ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
(Date:11/25/2015)... ATLANTA , Nov. 25, 2015 ... the first federal bellwether trial against Wright Medical ... relating to their Conserve metal-on-metal hip implant device, ... Christiansen.  Following a two week trial and three ... Conserve metal-on-metal hip device was defectively designed and ...
Breaking Medicine Technology: